Edgewise Therapeutics, Inc.

EWTXNASDAQHealthcare● Active

$34.62

$-0.97(-2.71%)

Market Cap$3.7B

P/E Ratio—

52W High$40.765

52W Low$12.15

Avg Volume1.1M

Open$35.50

Beta0.30

Forecast Market Cap PE Ratio

Edgewise Therapeutics, Inc.（EWTX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

ewtx · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 10 位华尔街分析师

Buy

10 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 10 · 买入占比: 80.0%

12 个月目标价

High

$66.00

Consensus

$47.57

+37.1% upside

Low

$25.00

Median: $48 · Last Close: $34.70

Edgewise Therapeutics, Inc.（EWTX）的分析师共识为 Buy，基于过去 3 个月内 10 位华尔街分析师的评级。EWTX 的 12 个月平均目标价为 $47.57，相对当前价 $34.70 代表 +37.1% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $48 (37.1%)High $66Low $25

Consensus Target

$47.57

37.1% upside

High Target

$66

90.2%

Low Target

$25

-28.0%

Current Price

$34.70

as of today

Based on analyst price targets, the EWTX stock price prediction for the next 12 months ranges from $25 to $66. The consensus EWTX price forecast of $47.57 implies 37.1% upside from the current price of $34.70.

短期股价预测

Bull

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$36.41	↑ 4.92%	$36.02	$36.79

1-day model range: $36.02–$36.79. Peak: $36.79 (+4.92%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$30	$32	$34	-8.4%
2028	$28	$30	$33	-13.0%
2029	$26	$29	$32	-15.6%
2030	$25	$29	$32	-17.1%
2031	$25	—	$32	-18.0%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%7%36%

8Buy

1Neutral

5Sell

RSI (14)58.5Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · EWTX · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$36.20SELL

MA 10$35.58SELL

MA 20$34.33BUY

MA 50$33.42BUY

MA 100$31.44BUY

MA 200$25.19BUY

Current $EWTX · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$35.73SELL

EMA 10$35.46SELL

EMA 20$34.76SELL

EMA 50$33.31BUY

EMA 100$30.96BUY

EMA 200$27.81BUY

Current $EWTX · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-06-02	Wedbush	Maintains	Outperform→Outperform
2026-06-02	HC Wainwright & Co.	Maintains	Buy→Buy
2026-06-02	RBC Capital	Maintains	Outperform→Outperform
2026-03-17	Wedbush	Maintains	Outperform→Outperform
2026-03-17	JP Morgan	Maintains	Overweight→Overweight
2026-02-27	Evercore ISI Group	Maintains	Outperform→Outperform
2025-11-14	JP Morgan	Maintains	Overweight→Overweight
2025-11-07	Wedbush	Maintains	Outperform→Outperform
2025-11-07	RBC Capital	Maintains	Outperform→Outperform
2025-08-19	JP Morgan	Maintains	Overweight→Overweight

Wedbush2026-06-02

Maintains

Outperform→Outperform

HC Wainwright & Co.2026-06-02

Maintains

Buy→Buy

RBC Capital2026-06-02

Maintains

Outperform→Outperform

Wedbush2026-03-17

Maintains

Outperform→Outperform

JP Morgan2026-03-17

Maintains

Overweight→Overweight

Evercore ISI Group2026-02-27

Maintains

Outperform→Outperform

JP Morgan2025-11-14

Maintains

Overweight→Overweight

Wedbush2025-11-07

Maintains

Outperform→Outperform

RBC Capital2025-11-07

Maintains

Outperform→Outperform

JP Morgan2025-08-19

Maintains

Overweight→Overweight

Wall Street analysts have recently issued updated ratings on Edgewise Therapeutics, Inc. (EWTX) stock. Of the recent 55 rating actions, 0 were upgrades and 2 were downgrades. 10 analysts currently cover EWTX.

分析师推荐趋势

Buy ratings1 → 3↑ +2

Hold ratings0 → 0

Sell ratings0 → 0

EWTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$2M

↓ 97.6% YoY

Revenue Next Year

$30M

↑ 1208.2% YoY

EPS This Year

$-1.94

EPS Next Year

$-1.85

↓ 4.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast EWTX EPS of $-1.94 for the current fiscal year, based on estimates from 7 analysts. The EWTX revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

EWTX 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。EWTX 的共识目标价为 $47.57（+37.1% 上行空间），分析师共识为 Buy。

EWTX 的短期预测（明日）为 $36.41（+4.92%）。 EWTX 对 2027 年的股价预测均值为 $32。 EWTX 对 2030 年的预测区间为 $25–$32。

Edgewise Therapeutics, Inc. 在 NASDAQ 上市，代码 EWTX。EWTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

EWTX 预测 · 8 个问题

根据 10 位华尔街分析师，EWTX 的 12 个月平均目标价为 $47.57，最高 $66.00、最低 $25.00。若有图表，中位目标价可在上方查看。相对当前价 $34.70，隐含约 +37.1% 的上行空间。

EWTX 目标价EWTX 分析师目标价EWTX 12个月目标价目标价 EWTX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.